{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:17Z","timestamp":1759333517589},"reference-count":26,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2003,12,24]],"date-time":"2003-12-24T00:00:00Z","timestamp":1072224000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p> <jats:italic>Hintergrund:<\/jats:italic> Die Wirksamkeit der Extrakorporalen Photopherese (ExP) bei Progressiver Systemischer Sklerodermie (PSS) wird kontrovers diskutiert. Bisher bestehen nur wenige Erfahrungen zur Langzeitanwendung der ExP bei PSS. Ziel vorliegender Untersuchung war es, bei der Anwendung von ExP bei PSS Responder von Non\u2010Respondern zu unterscheiden und geeignete Verlaufsparameter zu evaluieren.<\/jats:p><jats:p> <jats:italic>Patienten und Methodik:<\/jats:italic> Es wurden 20\u2005PSS\u2010Patienten w\u00e4hrend einer 12\u2010monatigen ExP\u2010Therapie (Intervall: 1x\/Monat) als immunmodulatorische Mono\u2010 (11\/20) oder Kombinationstherapie (9\/20) beobachtet. Der Verlauf der PSS wurde mittels eines eigens f\u00fcr die einheitliche Beurteilung der PSS\u2010Patienten etablierten klinischen Scores und serologischen Parametern (CRP, ANA\u2010Titer, beta\u2010Galaktosidase, P\u2010III\u2010P, CD4\/CD8\u2010Ratio, TNF\u2010alpha, Il\u20102\u2010R, Il\u20106) kontrolliert.<\/jats:p><jats:p> <jats:italic>Ergebnisse:<\/jats:italic> Nach 12\u2010monatiger ExP\u2010Therapie zeigten 30\u2003% der PSS\u2010Patienten eine partielle Remission und 25\u2003% einen stabilen Verlauf (55\u2003% Responder), w\u00e4hrend 45\u2003% eine Progression (Non\u2010Responder) aufwiesen. Zwar korrelierte der Krankheitsverlauf nicht mit den untersuchten laborchemischen Parametern, doch zeigte ein Anstieg der beta\u2010Galaktosidase unter Therapie bei den Non\u2010Respondern einen PSS\u2010Schub an. Bei den Respondern war ein kurzer Krankheitsverlauf vor ExP\u2010Beginn, moderat erh\u00f6hte ANA\u2010Titer, normwertige TNF\u2010alpha\u2010Spiegel sowie ein negativer Scl\u201070\u2010Nachweis prognostisch g\u00fcnstig einzusch\u00e4tzen.<\/jats:p><jats:p> <jats:italic>Schlussfolgerungen:<\/jats:italic> Etwa die H\u00e4lfte der PSS\u2010Patienten profitierten von einer langfristigen Wirksamkeit der ExP. Jedoch scheint die milde immunmodulatorische Wirkung der ExP nicht ausreichend, um stark progressive Verl\u00e4ufe der PSS zu kontrollieren.<\/jats:p>","DOI":"10.1046\/j.1439-0353.2003.03747.x","type":"journal-article","created":{"date-parts":[[2003,12,24]],"date-time":"2003-12-24T09:31:34Z","timestamp":1072258294000},"page":"945-951","source":"Crossref","is-referenced-by-count":4,"title":["Die Extrakorporale Photopherese bei Progressiver Systemischer Sklerodermie: Unterscheidung von Respondern und Non\u2010Respondern"],"prefix":"10.1111","volume":"1","author":[{"given":"Stefanie","family":"Reich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Radenhausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Altmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,12,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680130051005"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050973"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050387"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017927"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2340\/0001555573356561","article-title":"Photopheresis in systemic sclerosis: clinical and serological studies using markers of collagen metabolism","volume":"73","author":"Zachariae H","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246481"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70246-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb01488.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155599750010986"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)90341-0"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330828"},{"key":"e_1_2_5_13_2","first-page":"84","article-title":"The modified Rodnan Skin Score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst DE","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780220205"},{"key":"e_1_2_5_15_2","first-page":"41","article-title":"The acute phase response in scleroderma. Differing response to intravenous PGE1","volume":"4","author":"Smith EA","year":"1986","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05340.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350111"},{"key":"e_1_2_5_18_2","first-page":"663","article-title":"Elevated serum tumor necrosis factor\u2010alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis","volume":"24","author":"Hasegawa M","year":"1997","journal-title":"J Rheumatol"},{"key":"e_1_2_5_19_2","first-page":"687","article-title":"N\u2010Prokollagen(III)peptid und lysosomale beta\u2010Galaktosidase bei progressiver Sklerodermie und Silikose","volume":"176","author":"Schulze E","year":"1990","journal-title":"Dermatol Monatsschr"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70297-0"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050039"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155599750010986"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90011-2"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb01818.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70294-5"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.20.15220"},{"key":"e_1_2_5_27_2","first-page":"1936","article-title":"In situ expression and serum levels of tumor necrosis factor\u2010alpha in patients with early stages of systemic sclerosis","volume":"24","author":"Gruschwitz MS","year":"1997","journal-title":"J Rheumatol"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0353.2003.03747.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0353.2003.03747.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:42:52Z","timestamp":1697190172000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0353.2003.03747.x"}},"subtitle":["Extracorporeal photopheresis in progressive systemic sclerosis: discrimination of responders and non\u2010responders"],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1046\/j.1439-0353.2003.03747.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0353.2003.03747.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}